Early market access of cancer drugs in the EU
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/27/1/96/6677821/mdv506.pdf
Reference54 articles.
1. The European Medicines Agency: an overview of its mission, responsibilities, and recent initiatives in cancer drug regulation;Pignatti;Clin Cancer Res,2011
2. European Medicines Agency. Guideline on the Evaluation of Anticancer Medicinal Products in Man (EMA/CHMP/205/95/Rev.4).
3. Why do cancer drugs get such an easy ride?;Light;BMJ,2015
4. Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma;Eichler;Nat Rev Drug Discov,2008
5. Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response;Eichler;Nat Rev Drug Discov,2011
Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancing early access policies for innovative cancer drugs: a scoping review and explorative analysis in the Italian setting;Journal of Pharmaceutical Policy and Practice;2024-07-15
2. The impact of expanded access programs for systemic anticancer therapy in an Irish cancer centre;Irish Journal of Medical Science (1971 -);2024-05-28
3. Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and Costs;BioDrugs;2024-04-20
4. Availability and Access to Orphan Drugs for Rare Cancers in Bulgaria: Analysis of Delays and Public Expenditures;Cancers;2024-04-12
5. Uptake and availability of new outpatient cancer medicines in 2010–2021 in Nordic countries – survey of competent authorities;BMC Health Services Research;2023-12-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3